Moreover, p300-driven H3K9ac also appears to be involved in cardiomyopathy associated with loss-of-function mutations of Short-chain enoyl-CoA hydratase (ECHS1)—a key mitochondrial enzyme for fatty acid β-oxidation [128]. Here, EP300 is linked to cardiomyopathy.